Time to first remission and survival in patients with acromegaly: Evidence from the UK Acromegaly Register Study (UKAR).

Harshal DeshmukhEmmanuel SsemmondoKazeem AdelekeShiva MongoluMo Aye Steve Orme Daniel FlanaganPrakash AbrahamClaire HighamThozhukat Sathyapalannull null

Published in: Clinical endocrinology (2024)

In conclusion, this population-based study conducted in patients with acromegaly revealed that faster remission time, surgical intervention and treatment with SMA are linked to improved survival outcomes.

Keyphrases

growth hormone
disease activity
randomized controlled trial
ulcerative colitis
cross sectional
single cell
rheumatoid arthritis
systemic lupus erythematosus